Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 September 2025 | Story Reuben Maeko | Photo Sizwe Gwiba
Dermatology Unit
Celebrating the milestone launch of the Dermatologic Surgery Unit at Universitas Academic Hospital, a new chapter for advanced patient care, training, and research.

The Department of Dermatology in the Faculty of Health Sciences at the University of the Free State (UFS) marked a historic milestone with the official opening of the Dermatologic Surgery Unit at Universitas Academic Hospital on 11 September 2025. This new facility represents a significant step forward in expanding access to specialised surgical treatment for complex dermatological conditions, while simultaneously strengthening academic training and research opportunities for registrars and medical students.

The inauguration was attended by Prof Francois P Retief, a distinguished medical pioneer from the UFS Faculty of Health Sciences, after whom one of the faculty buildings is named. His wife, Ria Retief, extended words of gratitude and gifted a book from his medical library to Prof Frans Maruma, Head of the Department of Dermatology.

“We are truly honoured to be included in this significant milestone and to witness the beginning of what we know will be an impactful journey aimed at improving patient care,” Ria Retief said. “It is a privilege to celebrate this remarkable achievement with you, and we deeply admire your dedication and vision.”

 

Honouring a legacy in dermatology

In his opening address, Prof Maruma reflected on the journey that led to the establishment of the Dermatologic Surgery Unit, acknowledging the teamwork, persistence, and collaboration that made the vision a reality.

“The Derm-Surgery Unit is not just a surgical space – it is a testament to teamwork, perseverance, and the drive to advance patient-centred care in dermatology,” he said. “We pay homage to visionary leadership that has afforded us the opportunity to expand dermatology services to include surgery and as a skill sacrosanct to modern practice. This is not only about healing, but also about preparing our registrars for the realities of clinical practice through work-integrated learning.”

Prof Maruma extended appreciation to colleagues and staff members in the Department of Dermatology, as well as strategic partners in the UFS, the Department of Health, the pharmaceutical industry, and private practitioners who dedicate their time to teaching and mentoring. Special acknowledgement was given to Dr Marc Roscher, Dr Harriet Makuru, and Dr Yashica Khalawan, who played a pivotal role in supporting the project’s launch.

The programme also included remarks by senior academic leaders. Prof Alicia Sherriff, Acting Head of the School of Clinical Medicine, commended the department for its innovation and foresight in the face of resource limitations, highlighting the potential for further expansion through collaboration with both public and private stakeholders.

While cutting the ribbon, Prof Thabiso Mofokeng, Head of Internal Medicine at Universitas Academic Hospital, emphasised that the launch of the Derm-Surgery Unit reflects the broader ethos of the clinical platform: to enable world-class training, foster research excellence, and deliver quality healthcare that is responsive to the needs of the community.

The launch underscored the university’s commitment to Work-Integrated Learning (WIL), bridging the gap between academic training and real-world clinical demands. The Derm-Surgery initiative is designed to equip registrars with essential industry-specific skills in procedural dermatology while fostering collaboration between private and public healthcare sectors. The evening concluded with awards recognising individuals whose contributions ensured the success of this landmark opening.

Looking ahead, the Department of Dermatology envisions its Derm-Surgery Unit as more than just a clinical unit – it is set to become a hub of advanced patient care, high-impact training, and cutting-edge research. This initiative strengthens the UFS Faculty of Health Sciences’ role as a leader in medical education and healthcare innovation in the Free State and beyond.

News Archive

Link between champagne bubbles and the UFS?
2012-11-16

Prof. Lodewyk Kock with an example of a front page of the publication FEMS Yeast Research, as adapted by F. Belliard, FEMS Central Office.
Photo: Leatitia Pienaar
15 November 2012

What is the link between the bubbles in champagne and breakthrough research being done at the Mayo Clinic in America? Nano research being done at our university.

Prof. Lodewyk Kock of Biotechnology says a human being consists of millions of minute cells that are invisible to the eye. The nano technology team at the UFS have developed a technique that allows researchers to look into such a cell, as well as other microorganisms. In this way, they can get an idea of what the cell’s “insides” look like.

The UFS team – consisting of Profs. Kock, Hendrik Swart (Physics), Pieter van Wyk (Centre for Microscopy), as well as Dr Chantel Swart (Biotechnology), Dr Carlien Pohl (Biotechnology) and Liza Coetsee (Physics) – were amazed to see that the inside of cells consist of a maze of small tunnels or blisters. Each tunnel is about 100 and more nanometres in diameter – about one ten thousandth of a millimetre – that weaves through the cells in a maze.

It was also found that these tunnels are the “lungs” of the cells. Academics doing research on yeast have had to sit up and take notice of the research being done at the UFS – to the extent that these “lungs” will appear on the front page of the highly acclaimed FEMS Yeast Research for all of 2013.

The Mayo Clinic, in particular, now wants to work with the UFS to study cancer cells in more detail in order to fight this disease, says Prof. Kock. The National Cancer Institute of America has also shown interest. This new nano technology for biology can assist in the study and development of nano medicine that can be used in the treatment of cancer and other life threatening diseases. Nano medicine uses nano metal participles that are up to one billionth of a metre in size.

Prof. Kock says laboratory tests indicate that nano medicine can improve the efficacy of anti-cancer medicine, which makes the treatment less toxic. “According to the Mayo Clinic team, nano particles are considered as a gold cartridge which is being fired directly at a cancer tumour. This is compared to fine shot that spreads through the body and also attacks healthy cells.”

“This accuracy implies that the chemotherapy dose can be lowered with fewer side effects. The Mayo Clinic found that one-tenth of the normal dosage is more effective against pancreas cancer in this way than the full dosage with a linkage to nano particles. According to the clinic, this nano medicine could also delay the spread of cancer,” says Prof. Kock.

The nano particles are used as messengers that convey anti-cancer treatment to cancer cells, where it then selectively kills the cancer cells. The transport and transfer of these medicines with regard to gold nano particles can be traced with the UFS’s nano technology to collect more information, especially where it works on the cell.

“With the new nano technology of the UFS, it is possible to do nano surgery on the cells by slicing the cells in nanometre thin slices while the working of the nano medicine is studied. In this way, it can be established if the nano medicine penetrates the cells or if it is only associated with the tiny tunnels,” says Prof. Kock.

And in champagne the small “lungs” are responsible for the bubbles. The same applies to beer and with this discovery a whole new reach field opens for scientists.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept